These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 1879096)
41. Pharmacokinetics of newer drugs in patients with renal impairment (Part II). Singlas E; Fillastre JP Clin Pharmacokinet; 1991 May; 20(5):389-410. PubMed ID: 1879096 [TBL] [Abstract][Full Text] [Related]
42. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives. Srinivas NR Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465 [TBL] [Abstract][Full Text] [Related]
43. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Hoyer J; Schulte KL; Lenz T Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229 [TBL] [Abstract][Full Text] [Related]
44. Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously). Ogawa R; Stachnik JM; Echizen H Clin Pharmacokinet; 2013 Mar; 52(3):169-85. PubMed ID: 23344981 [TBL] [Abstract][Full Text] [Related]
45. Clinical pharmacokinetics of the newer antiarrhythmic agents. Gillis AM; Kates RE Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721 [TBL] [Abstract][Full Text] [Related]
49. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans. Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991 [TBL] [Abstract][Full Text] [Related]
50. Clinical pharmacology of propafenone. Connolly SJ; Kates RE; Lebsack CS; Harrison DC; Winkle RA Circulation; 1983 Sep; 68(3):589-96. PubMed ID: 6872170 [TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline. Canal M; Flouvat B; Tremblay D; Dufour A Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865 [TBL] [Abstract][Full Text] [Related]
52. Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug. Stefoni S; Docci D; Vangelista A; Mosconi G; Colí L; Prandini R Clin Nephrol; 1982 Oct; 18(4):168-73. PubMed ID: 6754197 [TBL] [Abstract][Full Text] [Related]
53. Investigations on the pharmacokinetics of propafenone in man. Hollmann M; Brode E; Hotz D; Kaumeier S; Kehrhahn OH Arzneimittelforschung; 1983; 33(5):763-70. PubMed ID: 6683556 [TBL] [Abstract][Full Text] [Related]
54. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Sum CY; Yacobi A; Kartzinel R; Stampfli H; Davis CS; Lai CM Clin Pharmacol Ther; 1983 Oct; 34(4):427-34. PubMed ID: 6617063 [TBL] [Abstract][Full Text] [Related]
55. Clinical pharmacokinetics of nimodipine in normal and impaired renal function. Kirch W; Rämsch KD; Dührsen U; Ohnhaus EE Int J Clin Pharmacol Res; 1984; 4(5):381-4. PubMed ID: 6519852 [TBL] [Abstract][Full Text] [Related]